Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 020865

Expand all

MAXALT-MLT (RIZATRIPTAN BENZOATE)
EQ 10MG BASE
Marketing Status: Prescription

Active Ingredient: RIZATRIPTAN BENZOATE
Proprietary Name: MAXALT-MLT
Dosage Form; Route of Administration: TABLET, ORALLY DISINTEGRATING; ORAL
Strength: EQ 10MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N020865
Product Number: 002
Approval Date: Jun 29, 1998
Applicant Holder Full Name: ORGANON LLC A SUB OF ORGANON AND CO
Marketing Status:  Prescription
Patent and Exclusivity Information

MAXALT-MLT (RIZATRIPTAN BENZOATE)
EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued

Active Ingredient: RIZATRIPTAN BENZOATE
Proprietary Name: MAXALT-MLT
Dosage Form; Route of Administration: TABLET, ORALLY DISINTEGRATING; ORAL
Strength: EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N020865
Product Number: 001
Approval Date: Jun 29, 1998
Applicant Holder Full Name: ORGANON LLC A SUB OF ORGANON AND CO
Marketing Status:  Discontinued
Patent and Exclusivity Information